Patents Assigned to HANGZHOU REX PHARMACEUTICAL CO., LTD.
  • Patent number: 10710993
    Abstract: The present invention discloses a compound for regulating protein kinase activity and used for treating or preventing diseases associated with protein kinases. Specifically, the present invention relates to a benzofuran pyrazole amine protein kinase inhibitor which belongs to compounds that regulate anaplastic lymphoma kinase (ALK), and provides a method of preparing such a compound and a pharmaceutical use of such a compound in the treatment or prevention of diseases associated with ALK. The inhibitor can solve the problem of the drug resistance of the first generation and the second generation of ALK inhibitors.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: July 14, 2020
    Assignee: HANGZHOU REX PHARMACEUTICAL CO., LTD.
    Inventors: Yonghui Wang, Juan Zhou, Yujun Gao, Dong Wang, Binbin Hong, Ximing Shen, Yaodong Wu, Chunqi Li